ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 8, 2016, Pages E1026-E1033

  Rolle, Anna Maria ^a   Hasenberg, Mike ^b   Thornton, Christopher R ^c   Solouk Saran, Djamschid ^b   Männ, Linda ^b   Weski, Juliane ^b   Maurer, Andreas ^a   Fischer, Eliane ^d   Spycher, Philipp R ^d   Schibli, Roger ^d   Boschetti, Frederic ^e   Stegemann Koniszewski, Sabine ^f,g   Bruder, Dunja ^f,g   Severin, Gregory W ^h   Autenrieth, Stella E ⁱ   Krappmann, Sven ^j   Davies, Genna ^c   Pichler, Bernd J ^a   Gunzer, Matthias ^b   Wiehr, Stefan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

^e UNIVERSITÉ DE BOURGOGNE   (France)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY HOSPITAL ERLANGEN   (Germany)

more..

Author keywords

Aspergillosis; Aspergillus fumigates; Imaging; Immunopet MR; PET

Indexed keywords

FLUOROCHROME; FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; TETRAXETAN CU 64; UNCLASSIFIED DRUG; FUNGUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; FLUORESCENCE IMAGING; FUNGAL DETECTION; FUNGUS HYPHAE; GROWTH CURVE; IN VIVO STUDY; LUNG MYCOSIS; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ANIMAL; DIAGNOSTIC IMAGING; HUMAN; LUNG ASPERGILLOSIS; PROCEDURES; RADIOGRAPHY;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ASPERGILLUS FUMIGATUS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; POSITRON-EMISSION TOMOGRAPHY; PULMONARY ASPERGILLOSIS; RADIOGRAPHY;

EID: 84959191475     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1518836113     Document Type: Article

References (43)

1. WHO (2014) World Health Statistics 2014. Available at apps.who.int/iris/bitstream/ 10665/112738/1/9789240692671-eng.pdf. Accessed August 10, 2015.
2. Brown GD, et al. (2012) Hidden killers: Human fungal infections. Sci Transl Med 4(165):165rv13.
3. Freifeld AG, et al.; Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56-e93.
4. Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5(10):609-622.
5. Prattes J, et al. (2014) Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med 190(8):922-929.
6. Glaudemans AW, Quintero AM, Signore A (2012) PET/MRI in infectious and inflammatory diseases: Will it be a useful improvement? Eur J Nucl Med Mol Imaging 39(5):745-749.
7. Signore A, Mather SJ, Piaggio G, Malviya G, Dierckx RA (2010) Molecular imaging of inflammation/infection: Nuclear medicine and optical imaging agents and methods. Chem Rev 110(5):3112-3145.
8. Wehrl HF, et al. (2014) Preclinical and Translational PET/MR Imaging. J Nucl Med 55:(Supplement 2):11S-18S.
9. Elsässer-Beile U, et al. (2009) PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. J Nucl Med 50(4):606-611.
10. Reichenberger F, Habicht JM, Gratwohl A, Tamm M (2002) Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 19(4):743-755.
11. Pichler BJ, Kolb A, Nägele T, Schlemmer HP (2010) PET/MRI: Paving the way for the next generation of clinical multimodality imaging applications. J NuclMed 51(3):333-336.
12. Coombes JL, Robey EA (2010) Dynamic imaging of host-pathogen interactions in vivo. Nat Rev Immunol 10(5):353-364.
13. Signore A, Glaudemans AW(2011) The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med 25(10):681-700.
14. Glaudemans AW, Signore A (2010) FDG-PET/CT in infections: The imaging method of choice? Eur J Nucl Med Mol Imaging 37(10):1986-1991.
15. Guimarães MD, et al. (2013) Fungal infection mimicking pulmonary malignancy: Clinical and radiological characteristics. Lung 191(6):655-662.
16. Hot A, et al. (2011) Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 17(3): 409-417.
17. Wang Y, et al. (2013) Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA. Nucl Med Biol 40(1):89-96.
18. Harry VN, Semple SI, Parkin DE, Gilbert FJ (2010) Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol 11(1):92-102.
19. Mortimer JE, et al. (2014) Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. J Nucl Med 55(1):23-29.
20. Tamura K, et al. (2013) 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer. J Nucl Med 54(11):1869-1875.
21. Wu AM, Olafsen T (2008) Antibodies for molecular imaging of cancer. Cancer J 14(3): 191-197.
22. Glaudemans AW, Slart RH, van Dijl JM, van Oosten M, van Dam GM (2015) Molecular imaging of infectious and inflammatory diseases: A terra incognita. J Nucl Med 56(5): 659-661.
23. Signore A, Glaudemans AW, Galli F, Rouzet F (2015) Imaging infection and inflammation. BioMed Res Int 2015:615150.
24. Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW (2013) Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem 24(12):1971-1989.
25. Ning X, et al. (2014) PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl 53(51):14096-14101.
26. Weinstein EA, et al. (2014) Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med 6(259):259ra146.
27. Langer O, et al. (2005) In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging 32(2):143-150.
28. Mills B, et al. (2015) [(18)F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections. EJNMMI Res 5:13.
29. Haas H, Petrik M, Decristoforo C (2015) An iron-mimicking, Trojan horse-entering fungi-has the time come for molecular imaging of fungal infections? PLoS Pathog 11(1):e1004568.
30. Petrik M, et al. (2010) 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: Proof of principle. J Nucl Med 51(4):639-645.
31. Holden VI, Bachman MA (2015) Diverging roles of bacterial siderophores during infection. Metallomics 7(6):986-995.
32. Thornton CR, Wills OE (2015) Immunodetection of fungal and oomycete pathogens: Established and emerging threats to human health, animal welfare and global food security. Crit Rev Microbiol 41(1):27-51.
33. Santangelo PJ, et al. (2015) Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods 12(5):427-432.
34. Thornton CR (2008) Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 15(7): 1095-1105.
35. Tavaré R, et al. (2014) Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. Proc Natl Acad Sci USA 111(3):1108-1113.
36. White PL, Parr C, Thornton C, Barnes RA (2013) Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol 51(5):1510-1516.
37. Wiederhold NP, et al. (2013) Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis. J Clin Microbiol 51(2):459-465.
38. Pan Z, et al. (2015) Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: A meta-analysis. J Med Microbiol 64(7):702-707.
39. Wiehr S, et al. (2014) Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody. Prostate 74(7):743-755.
40. Hearn VM, Mackenzie DW (1980) Mycelial antigens from two strains of Aspergillus fumigatus: An analysis by two-dimensional immunoelectrophoresis. Mykosen 23(10): 549-562.
41. Hasenberg A, et al. (2015) Catchup: A mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat Methods 12(5):445-452.
42. Hasenberg M, Köhler A, Bonifatius S, Jeron A, Gunzer M (2011) Direct observation of phagocytosis and NET-formation by neutrophils in infected lungs using 2-photon microscopy. J Vis Exp 52:2659.
43. Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of nocarrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27(2):235-238.